Designing gene therapy vectors: avoiding immune responses by using tissue-specific promoters.
about
DNA vaccines: improving expression of antigensPlatelets as delivery systems for disease treatmentsIntraganglionic AAV6 results in efficient and long-term gene transfer to peripheral sensory nervous system in adult rats.Comparative analysis of macrophage associated vectors for use in genetic vaccineApproaches to enhance the efficacy of DNA vaccines.DNA-based therapeutics and DNA delivery systems: a comprehensive review.Reducing the immunostimulatory activity of CpG-containing plasmid DNA vectors for non-viral gene therapy.AAV-directed muscular dystrophy gene therapy.Nucleic-acid based gene therapeutics: delivery challenges and modular design of nonviral gene carriers and expression cassettes to overcome intracellular barriers for sustained targeted expression.Recent advances in gene therapy for lysosomal storage disorders.State of play and clinical prospects of antibody gene transfer.Optimized lentiviral vector production and purification procedure prevents immune response after transduction of mouse brain.Gene therapy with an improved doxycycline-regulated plasmid encoding a tumour necrosis factor-alpha inhibitor in experimental arthritisConstruction and analysis of compact muscle-specific promoters for AAV vectors.Partial rescue of growth failure in growth hormone (GH)-deficient mice by a single injection of a double-stranded adeno-associated viral vector expressing the GH gene driven by a muscle-specific regulatory cassette.Muscle stem cells can act as antigen-presenting cells: implication for gene therapy.Long-term expression of full-length human dystrophin in transgenic mdx mice expressing internally deleted human dystrophins.Molecular barcoding of viral vectors enables mapping and optimization of mRNA trans-splicing.Prolonged in vivo expression and anti-tumor response of DNA-based anti-HER2 antibodies.
P2860
Q24806169-8B04AD81-8A80-46DF-BB72-1D3A32A3900AQ34348837-711E3D85-BC31-42C4-90E6-B5F273DA24B6Q34684229-CEE94EEE-AFCA-4F35-BE6F-D89060E6819EQ35137219-6EF3B424-FDF4-49F8-93DE-75DE633DC7C9Q35743279-60B908FB-CDE0-471B-9C56-81E89C87EB1FQ36250777-B346D3E1-A9F7-4A29-BE1A-DEC8307F4860Q36316635-539523C3-A5D7-4A1D-8370-8A956E0CDC4BQ37687423-DA89F6C0-3703-4667-A632-B458D20B8FE9Q37981217-D366486F-A0A6-4092-9258-33937ED48BD8Q38546492-D260C00F-FDA0-4C8C-8AAE-6437621DDDD4Q38737706-7DD01DBB-3F04-47A7-B95D-DE1FFC175F3FQ40557969-AA167170-07EF-4BDF-BC8C-406920D96D75Q42222701-EEC8645B-956F-4509-BE46-7ACDC56078B2Q42437569-E8F76A52-9032-483F-8D0D-CF1D556BBBFFQ42590798-2C672385-687E-4F6B-82E2-DC9F091D0E5DQ44431486-12EAE90E-B141-4890-8790-F66602423E00Q45873225-9EDA46DF-77EE-49C9-A66B-F1003119271AQ47547468-206BF193-786B-4A53-A46C-AB09B9EB3D46Q55241055-12AA551A-E86F-49B1-AE4B-4827A170B6D6
P2860
Designing gene therapy vectors: avoiding immune responses by using tissue-specific promoters.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Designing gene therapy vectors ...... ing tissue-specific promoters.
@en
Designing gene therapy vectors ...... ing tissue-specific promoters.
@nl
type
label
Designing gene therapy vectors ...... ing tissue-specific promoters.
@en
Designing gene therapy vectors ...... ing tissue-specific promoters.
@nl
prefLabel
Designing gene therapy vectors ...... ing tissue-specific promoters.
@en
Designing gene therapy vectors ...... ing tissue-specific promoters.
@nl
P2093
P2860
P356
P1433
P1476
Designing gene therapy vectors ...... ing tissue-specific promoters.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.GT.3301602
P577
2001-12-01T00:00:00Z
P5875
P6179
1025068365